| Dr Daniel Alejandro Cortez, MD | |
|
6501 Coyle Ave, Dept Of Pathology, Carmichael, CA 95608-0306 | |
| (916) 537-5275 | |
| (916) 672-1524 |
| Full Name | Dr Daniel Alejandro Cortez |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 18 Years |
| Location | 6501 Coyle Ave, Carmichael, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437315769 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZC0500X | Pathology - Cytopathology | A107614 (California) | Secondary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | A107614 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Clovis Community Medical Center | Clovis, CA | Hospital |
| Community Regional Medical Center | Fresno, CA | Hospital |
| Adventist Health Hanford | Hanford, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pathology Associates | 9133168784 | 16 |
News Archive
Invading glioblastoma cells may hijack cerebral blood vessels during early stages of disease progression and damage the brain's protective barrier, a study in mice indicates. This finding could ultimately lead to new ways to bring about the death of the tumor, as therapies may be able to reach these deadly cells at an earlier time point than was previously thought possible.
Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that it has received a Notice of Issuance from the U.S. Patent and Trademark Office for its patent application entitled "ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS", U.S. Patent No.: 8,410,088.
A study using a driving simulator suggests that adolescents with attention-deficit/hyperactivity disorder (ADHD) who were distracted while driving demonstrated more variability in speed and lane position than adolescents without ADHD, according to a study published by JAMA Pediatrics, a JAMA Network publication.
Vantage Communications, an award-winning global PR firm, today announced that it is the agency of record for ImThera Medical, Inc. Within a few months, Vantage Communications successfully promoted ImThera and its medical device technology with original coverage garnered in top-tier publications such as Neurotech Insights, ENToday, The Gray Sheet, Sleep Review, Respiratory & Sleep Management, Respiratory Therapy, Medical Device Daily, and medGadget.
Further evidence that using cannabis could increase the risk of developing a psychotic illness such as schizophrenia, later in life, is revealed today in a study published in The Lancet.
› Verified 7 days ago
| Entity Name | Lucent Pathology Partners Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124098736 PECOS PAC ID: 8325087034 Enrollment ID: O20050502000476 |
News Archive
Invading glioblastoma cells may hijack cerebral blood vessels during early stages of disease progression and damage the brain's protective barrier, a study in mice indicates. This finding could ultimately lead to new ways to bring about the death of the tumor, as therapies may be able to reach these deadly cells at an earlier time point than was previously thought possible.
Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that it has received a Notice of Issuance from the U.S. Patent and Trademark Office for its patent application entitled "ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS", U.S. Patent No.: 8,410,088.
A study using a driving simulator suggests that adolescents with attention-deficit/hyperactivity disorder (ADHD) who were distracted while driving demonstrated more variability in speed and lane position than adolescents without ADHD, according to a study published by JAMA Pediatrics, a JAMA Network publication.
Vantage Communications, an award-winning global PR firm, today announced that it is the agency of record for ImThera Medical, Inc. Within a few months, Vantage Communications successfully promoted ImThera and its medical device technology with original coverage garnered in top-tier publications such as Neurotech Insights, ENToday, The Gray Sheet, Sleep Review, Respiratory & Sleep Management, Respiratory Therapy, Medical Device Daily, and medGadget.
Further evidence that using cannabis could increase the risk of developing a psychotic illness such as schizophrenia, later in life, is revealed today in a study published in The Lancet.
› Verified 7 days ago
| Entity Name | Pathology Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144277633 PECOS PAC ID: 9133168784 Enrollment ID: O20050503000488 |
News Archive
Invading glioblastoma cells may hijack cerebral blood vessels during early stages of disease progression and damage the brain's protective barrier, a study in mice indicates. This finding could ultimately lead to new ways to bring about the death of the tumor, as therapies may be able to reach these deadly cells at an earlier time point than was previously thought possible.
Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that it has received a Notice of Issuance from the U.S. Patent and Trademark Office for its patent application entitled "ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS", U.S. Patent No.: 8,410,088.
A study using a driving simulator suggests that adolescents with attention-deficit/hyperactivity disorder (ADHD) who were distracted while driving demonstrated more variability in speed and lane position than adolescents without ADHD, according to a study published by JAMA Pediatrics, a JAMA Network publication.
Vantage Communications, an award-winning global PR firm, today announced that it is the agency of record for ImThera Medical, Inc. Within a few months, Vantage Communications successfully promoted ImThera and its medical device technology with original coverage garnered in top-tier publications such as Neurotech Insights, ENToday, The Gray Sheet, Sleep Review, Respiratory & Sleep Management, Respiratory Therapy, Medical Device Daily, and medGadget.
Further evidence that using cannabis could increase the risk of developing a psychotic illness such as schizophrenia, later in life, is revealed today in a study published in The Lancet.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Daniel Alejandro Cortez, MD Po Box 340850, Sacramento, CA 95834-0850 Ph: (916) 634-7767 | Dr Daniel Alejandro Cortez, MD 6501 Coyle Ave, Dept Of Pathology, Carmichael, CA 95608-0306 Ph: (916) 537-5275 |
News Archive
Invading glioblastoma cells may hijack cerebral blood vessels during early stages of disease progression and damage the brain's protective barrier, a study in mice indicates. This finding could ultimately lead to new ways to bring about the death of the tumor, as therapies may be able to reach these deadly cells at an earlier time point than was previously thought possible.
Epizyme, Inc., a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that it has received a Notice of Issuance from the U.S. Patent and Trademark Office for its patent application entitled "ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS", U.S. Patent No.: 8,410,088.
A study using a driving simulator suggests that adolescents with attention-deficit/hyperactivity disorder (ADHD) who were distracted while driving demonstrated more variability in speed and lane position than adolescents without ADHD, according to a study published by JAMA Pediatrics, a JAMA Network publication.
Vantage Communications, an award-winning global PR firm, today announced that it is the agency of record for ImThera Medical, Inc. Within a few months, Vantage Communications successfully promoted ImThera and its medical device technology with original coverage garnered in top-tier publications such as Neurotech Insights, ENToday, The Gray Sheet, Sleep Review, Respiratory & Sleep Management, Respiratory Therapy, Medical Device Daily, and medGadget.
Further evidence that using cannabis could increase the risk of developing a psychotic illness such as schizophrenia, later in life, is revealed today in a study published in The Lancet.
› Verified 7 days ago
Dr. Reggie Zhan, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 3637 Mission Ave, Suite 5, Carmichael, CA 95608 Phone: 916-863-1496 | |
Dr. Jonathan Edward Musicant, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 6501 Coyle Ave, Carmichael, CA 95608 Phone: 916-537-5275 | |
Pranav Gandhi, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 6501 Coyle Ave, Carmichael, CA 95608 Phone: 916-537-5275 | |
Dr. Larry Lieb, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 1921 Lowland Ct, Carmichael, CA 95608 Phone: 916-483-3603 Fax: 916-481-5132 | |
Dr. Adina Alexandra Bodolan, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 6501 Coyle Avenue, Carmichael, CA 95608 Phone: 916-860-4460 | |
Alejandro Saropdas Mendoza, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: Mercy San Juan Medical Center, 6501 Coyle Avenue, Carmichael, CA 95608 Phone: 916-778-8999 Fax: 916-672-1524 |